Medical Device · Renal Health
QuinSense is developing a wearable biosensor platform designed to give dialysis patients and their physicians real-time visibility into kidney health.
Learn moreThe Problem
Chronic kidney disease affects tens of millions of Americans. Today, monitoring relies on infrequent clinical visits and reactive care — leaving patients and physicians without the continuous data needed to intervene early and reduce hospitalizations.
Our Approach
We are building a proprietary wearable biosensor platform that provides continuous biomarker tracking — giving patients and clinicians the data they need to make timely, informed care decisions and reduce the burden of late-stage interventions.
Our device tracks clinically relevant kidney biomarkers around the clock, replacing periodic snapshots with a continuous stream of actionable physiological data.
Trend analysis and intelligent alerting help patients and physicians identify physiological risk events before they escalate into hospitalizations.
A companion app delivers live readings and longitudinal data to both patients and their care teams, enabling coordinated care from anywhere.
Why It Matters
No wearable device currently offers continuous, kidney-specific biomarker monitoring. QuinSense is positioned to fill that gap — enabling proactive care where only reactive care exists today.
The Team
QuinSense brings together expertise in bioelectronics, mechanical engineering, software, clinical science, finance, and regulatory affairs — all united around a single mission.
Get In Touch
Whether you're a potential partner, clinician, investor, or patient advocate — we'd love to hear from you.
admin@quinsense.comHouston, Texas · Seed Stage
QuinSense is a pre-clinical medical device startup focused on transforming how dialysis patients monitor and manage their kidney health. We are actively seeking strategic partnerships, clinical collaborators, and mission-aligned investors to accelerate our development timeline.